Filgrastim (pronounced [fil GRA stim]) is also known by the brand name Neupogen. Other available biosimilars include Zarxio, Granix, and Nivestym. Neupogen was the first medication produced based on the active element, filgrastim. These drugs have been used successfully for
Pegfilgrastim (pronounced [peg fil GRA stim]), which is also known by the brand name, Neulasta, is a hematopoietic agent that is used to treat neutropenia. Neulasta was the first medication produced based on the active element pegfilgrastim. Pegfilgrastim is not
Neuropathy is a general term referring to the condition that results from damage or dysfunction of one or more nerves. It is often called “peripheral neuropathy” because symptoms commonly manifest as numbness, weakness, tingling, and/or sometimes pain, which usually starts
Idiopathic Thrombocytopenic Purpura (ITP) is an immune disorder that manifests itself through abnormal blood clotting. The term "immune thrombocytopenia" is used more commonly to refer to this condition. ITP is caused by a low platelet count in the blood.
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow cells that generally develops gradually. CLL is one of the most common types of cancer in adults. It usually occurs after adulthood, and its prevalence is rare
Hypogammaglobulinemia is a disorder caused by low levels of serum immunoglobulins or antibodies. Immunoglobulins (IG) are the main components of immune response and can recognize antigens (foreign substances) to trigger an immune response and eliminate the infection. There are several